Linh H. Le

Mr. Linh H. Le brings more than two decades of work experiences in the healthcare space, stemming from several industry sectors including molecular diagnostics, infectious diseases, and medical devices. He comes to Mindera from Predicine, where he served as Chief Financial Officer, leading key financial and infrastructure changes that enabled scalability and operational excellence across the enterprise. His prior experience includes Ambry Genetics, where he was Chief Operating Officer, and Medtronic Diabetes Group, where he has held various leadership positions of increased responsibilities over a span of fourteen years. Before his time at Medtronic, Linh’s experiences include leadership roles at the Walt Disney Company and management advisory services with PricewaterhouseCoopers.  Lastly, Linh began his professional career in the assurance practice of KPMG, providing attestation services in the healthcare and technology practices where he earned his CPA designation.  Linh was named LA Times CFO of the year in 2022.